188 related articles for article (PubMed ID: 21573834)
1. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract][Full Text] [Related]
2. Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.
Oh CA; Bae JM; Oh SJ; Choi MG; Noh JH; Sohn TS; Kim S
J Surg Oncol; 2012 Mar; 105(4):393-9. PubMed ID: 21898416
[TBL] [Abstract][Full Text] [Related]
3. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
5. Borrmann's type IV gastric cancer: clinicopathologic analysis.
Yokota T; Teshima S; Saito T; Kikuchi S; Kunii Y; Yamauchi H
Can J Surg; 1999 Oct; 42(5):371-6. PubMed ID: 10526523
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
7. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis.
Saito H; Kihara K; Kuroda H; Matsunaga T; Tatebe S; Ikeguchi M
J Surg Oncol; 2011 Oct; 104(5):534-7. PubMed ID: 21618248
[TBL] [Abstract][Full Text] [Related]
10. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of peritoneal washing cytology in patients with gastric cancer.
Lee SD; Ryu KW; Eom BW; Lee JH; Kook MC; Kim YW
Br J Surg; 2012 Mar; 99(3):397-403. PubMed ID: 22101572
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
13. [Problems of surgical management of Borrmann's type IV stomach cancer--with special reference to subdivision of Borrmann's type IV].
Kito T
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2461-7. PubMed ID: 6651306
[TBL] [Abstract][Full Text] [Related]
14. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences.
La Torre M; Ferri M; Giovagnoli MR; Sforza N; Cosenza G; Giarnieri E; Ziparo V
Eur J Surg Oncol; 2010 Oct; 36(10):982-6. PubMed ID: 20591604
[TBL] [Abstract][Full Text] [Related]
18. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
20. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients.
Mezhir JJ; Shah MA; Jacks LM; Brennan MF; Coit DG; Strong VE
Ann Surg Oncol; 2010 Dec; 17(12):3173-80. PubMed ID: 20585870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
